Both in Pharmaceuticals
Annexon vs Aclaris Therapeutics
Over the past year ANNX returned +32.4% and ACRS returned +175.0%; their daily moves had a correlation of 0.23.
ANNX +32.4% ACRS +175.0%Growth of $1, one year, split-adjusted
| Metric | ANNX | ACRS |
|---|---|---|
| Price | $4.13 | $5.28 |
| Market cap | $783.0M | $777.2M |
| Today | +2.99% | −2.76% |
| 1 month | −16.9% | −12.1% |
| 6 months | −16.7% | +51.3% |
| Year to date | −17.7% | +75.4% |
| 1 year | +22.6% | +165.3% |
| Revenue growth (YoY) | — | −8.3% |
| Gross margin | — | 86.6% |
| Net margin | — | −1320.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 94.6× |
| Net cash | $209.2M | $91.6M |
| Dividend yield | — | — |
| Volatility (60d) | 68.8% | 56.9% |
| Short % of float | 21.4% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).